Sector & Market
Apogee CMO Dambkowski Sells $738k Shares
Carl Dambkowski, Apogee Therapeutics CMO, sold 5,500 shares for $737,934 on Aug 5, 2026 via Rule 10b5‑1 plan.
He simultaneously exercised 4,125 stock options at $22.86, spending $94,297, part of a 175
